Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New eye drops aim to soothe painful eye injuries in rare skin disease

NCT ID NCT06713434

First seen Jan 08, 2026 · Last updated May 24, 2026 · Updated 22 times

Summary

This study tests whether ELK-003 eye drops can safely ease eye symptoms in people with junctional or dystrophic epidermolysis bullosa (EB), a rare genetic condition causing fragile skin and frequent eye injuries. About 20 participants will first be observed, then use the drops 6 times daily. The goal is to see if the drops reduce painful corneal abrasions and other eye problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fundación DEBRA Chile, Niños Piel de Cristal

    Santiago, Huechuraba, 8580670, Chile

Conditions

Explore the condition pages connected to this study.